National Vision Holdings Inc. (EYE)
NASDAQ: EYEHealth CareOphthalmic GoodsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EYE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.31B
- P/E (TTM)
- 20.39
- Forward P/E
- 14.31
- EPS (TTM)
- $0.82
- Dividend yield
- None
- 52-week range
- 14.75 – 30.02
- Day range
- 16.59 – 17.62
- Volume / Avg
- 1.33M / 2.14M
- Beta
- —
- Shares outstanding
- 78.07M
52-week range
EYE stock today
National Vision (EYE) closed at $16.72 on Nov 20, down 1.70% (-$0.29), versus the S&P 500's 3.70% decline. Shares are 44.3% below their 52-week high of $30.02, set on Jan 15, 2026 and 13.4% above the 52-week low of $14.75, near the bottom of the past year's range. EYE is down 35.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 37.1%.
At 20.4x trailing earnings, National Vision trades below the peer-group median of 37.2x. Its forward P/E of 14.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About National Vision
Company profileNational Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- CEO
- Mr. Alexander N. Wilkes
- Headquarters
- Duluth, GA
- Employees
- 13,138
- IPO year
- 2017
- Website
- nationalvision.com
Financial highlights
Full financialsIn fiscal 2025, National Vision generated $1.99 billion in revenue, up 9.0% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $29.6 million, for a net margin of 1.5% versus a median of 2.1% in the prior 5 years. Gross margin was 58.8% (up from 58.1%) and operating margin 3.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.99B | $1.82B | $1.76B | $1.64B | $2.08B |
| Growth | +9.00% | +3.81% | +6.79% | -20.91% | +21.48% |
| Net income | $29.60M | $-28.50M | $-65.90M | $42.12M | $128.24M |
| EPS (diluted) | $0.37 | $-0.36 | $-0.84 | $0.52 | $1.43 |
Analyst forecast
ForecastConsensus (11 analysts)
buy
Avg. price target
$27.00+61.48%
- Strong buy 1
- Buy 7
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $0.23 vs $0.06
- Surprise
- +283.33%
EYE news
All EYE news- National Vision plans 50 to 55 store openings in 2027 as it forecasts $2.02B to $2.04B in 2026 revenueSeeking Alpha
- National Vision Holdings, Inc. Reports Third Quarter 2026 Financial Results and Updates Fiscal 2026 OutlookNasdaqEYE, BRK.A
- Nemours Children's Health Brings Leading Industry Experts Together to Advance National Vision for Pediatric Care in the Home SettingPR Newswire
- National Vision Q3 Profit Surges On Higher Sales And Margin Expansion; Updates Fiscal 2026 OutlookNasdaqEYE, BRK.B
- National Vision Q3 Profit Jumps To $19.2 Million; Updates FY26 OutlookNasdaqEYE, MOG.A
- National Vision Holdings, Inc. Reports Increase In Q3 IncomeNasdaq
- National Vision Holdings reports mixed Q3 results; updates FY26 outlookSeeking Alpha
- National Vision Holdings, Inc. Reports Third Quarter 2026 Financial ResultsBusiness Wire
National Vision peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STAASTAAR Surgical Company | 24.22 | -3.24% | $1.22B | vs EYE |
| RXSTRxSight Inc. | 4.47 | -3.04% | $187.42M | vs EYE |
| LUCYInnovative Eyewear Inc. | 0.7025 | -0.07% | $6.12M | vs EYE |
| WRBYWarby Parker Inc. Class A | 23.12 | -4.19% | $2.87B | vs EYE |
| BLCOBausch + Lomb Corporation | 19.38 | -6.33% | $6.93B | vs EYE |
| COOThe Cooper Companies Inc. | 58.88 | -2.40% | $11.20B | vs EYE |
| ALCAlcon Inc. | 74.31 | -0.26% | $35.70B | vs EYE |
Indexes, lists and sector
National Vision stock FAQ
What is National Vision's stock price today?
EYE last traded at $16.72 as of Nov 20, 4:00 PM EST, down 1.70% on the day. Prices are delayed at least 15 minutes.
What is EYE's P/E ratio?
EYE trades at a trailing P/E ratio of 20.39 and a forward P/E of 14.31, compared with a median of 37.2 for its closest peers.
Who is National Vision's CEO?
Mr. Alexander N. Wilkes is the chief executive officer of National Vision Holdings Inc., which has about 13,138 employees.
What is the EYE 52-week high?
The 52-week high for EYE is $30.02 and the 52-week low is $14.75. The stock is currently 44.3% below its high.